Palladio Biosciences: Funding, Investors & Team (Sep 2026)
Palladio Bio is a clinical-stage company developing transformative medicines for orphan diseases of the kidney. The company specializes in the fields of biotechnology, pharmaceutical. and therapeutics. Its products are designed for renal disease, kidney disease, and polycystic kidney disease. The company was founded in 2015 and headquartered in Horsham, Pennsylvania.
Palladio Biosciences has raised $20.0M across 1 funding round on record, the most recent an undisclosed round of $20.0M announced in Sep 2020.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Palladio Biosciences Company Profile and Key Stats
Latest funding round on record: Sep 2020.
Palladio Biosciences Funding Rounds
Palladio Biosciences Founders and Leadership Team
Contact details for the Palladio Biosciences team: 1 of 1 has an email address on file.
Start 14-day free trial →Palladio Biosciences Funding Compared to Other Biotechnology Startups
Palladio Biosciences' latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Palladio Biosciences in Biotechnology and Horsham
Companies Similar to Palladio Biosciences
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Palladio Biosciences Funding FAQs
What does Palladio Biosciences do?
Palladio Bio is a clinical-stage company developing transformative medicines for orphan diseases of the kidney. The company specializes in the fields of biotechnology, pharmaceutical. and therapeutics. Its products are designed for renal disease, kidney disease, and polycystic kidney disease. The company was founded in 2015 and headquartered in Horsham, Pennsylvania.
How much funding has Palladio Biosciences raised?
Palladio Biosciences has raised $20.0M across 1 round on record. The most recent is an undisclosed round of $20.0M announced in Sep 2020.
When did Palladio Biosciences last raise funding?
Palladio Biosciences' most recent funding round on record is an undisclosed round of $20.0M, announced in Sep 2020.
Who is the CEO of Palladio Biosciences?
Alex Martin is listed as CEO at Palladio Biosciences.
Where is Palladio Biosciences headquartered?
Palladio Biosciences is based in Horsham, Pennsylvania, United States.
How many employees does Palladio Biosciences have?
Palladio Biosciences is in the 11-50 employee band.
How does Palladio Biosciences' funding compare to other Biotechnology startups?
Palladio Biosciences' latest round of $20.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Palladio Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Palladio Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.